These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 30682070)

  • 1. Prognostic significance of DAPK promoter methylation in lymphoma: A meta-analysis.
    Wang H; Zhou LY; Guan ZB; Zeng WB; Zhou LL; Liu YN; Pan XY
    PLoS One; 2019; 14(1):e0210943. PubMed ID: 30682070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Death-associated protein kinase promoter methylation correlates with clinicopathological and prognostic features in nonsmall cell lung cancer patients: A cohort study.
    Yang XY; Zhang J; Yu XL; Zheng GF; Zhao F; Jia XJ
    J Cancer Res Ther; 2018; 14(Supplement):S65-S71. PubMed ID: 29578152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical significance of DAPK promoter hypermethylation in lung cancer: a meta-analysis.
    Li Y; Zhu M; Zhang X; Cheng D; Ma X
    Drug Des Devel Ther; 2015; 9():1785-96. PubMed ID: 25848215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinicopathological significance of DAPK gene promoter hypermethylation in non-small cell lung cancer: A meta-analysis.
    Chen Z; Fan Y; Liu X; Shang X; Qi K; Zhang S
    Int J Biol Markers; 2022 Mar; 37(1):47-57. PubMed ID: 34935548
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical effect of DAPK promoter methylation in gastric cancer: A systematic meta-analysis.
    Jia W; Yu T; Cao X; An Q; Yang H
    Medicine (Baltimore); 2016 Oct; 95(43):e5040. PubMed ID: 27787359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between promoter methylation of DAPK gene and HNSCC: A meta-analysis.
    Cai F; Xiao X; Niu X; Zhong Y
    PLoS One; 2017; 12(3):e0173194. PubMed ID: 28249042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DAPK Promoter Methylation and Bladder Cancer Risk: A Systematic Review and Meta-Analysis.
    Dai L; Ma C; Zhang Z; Zeng S; Liu A; Tang S; Ren Q; Sun Y; Xu C
    PLoS One; 2016; 11(12):e0167228. PubMed ID: 27907054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of hypermethylation of death-associated protein kinase (DAPK) gene CpG island in dogs with high-grade B-cell lymphoma.
    Sato M; Mochizuki H; Goto-Koshino Y; Fujiwara-Igarashi A; Takahashi M; Ohno K; Tsujimoto H
    Vet Comp Oncol; 2018 Sep; 16(3):409-415. PubMed ID: 29527805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DAPK promoter methylation status correlates with tumor metastasis and poor prognosis in patients with non-small cell lung cancer.
    Zhang J; Yu XL; Zheng GF; Zhao F
    Cancer Biomark; 2015; 15(5):609-17. PubMed ID: 26406950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Promoter methylation of DAPK gene may contribute to the pathogenesis of nonsmall cell lung cancer: a meta-analysis.
    Li FF; Yang Y; Wang XL; Hong YY; Wang NF; Chen ZD
    Tumour Biol; 2014 Jun; 35(6):6011-20. PubMed ID: 24659425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypermethylation of p15 gene in diffuse - large B-cell lymphoma: association with less aggressiveness of the disease.
    Krajnović M; Jovanović MP; Mihaljević B; Anđelić B; Tarabar O; Knežević-Ušaj S; Krtolica K
    Clin Transl Sci; 2014 Oct; 7(5):384-90. PubMed ID: 24815848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of aberrant promoter hypermethylation of CpG islands in patients with diffuse large B-cell lymphomas.
    Amara K; Trimeche M; Ziadi S; Laatiri A; Hachana M; Korbi S
    Ann Oncol; 2008 Oct; 19(10):1774-86. PubMed ID: 18539616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Promoter hypermethylation of PTPL1, PTPN6, DAPK, p16 and 5-azacitidine inhibits growth in DLBCL.
    Wang W; Wang J; Li Z; Zhu M; Zhang Z; Wang Y; Jing H
    Oncol Rep; 2016 Jan; 35(1):139-46. PubMed ID: 26498513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypermethylation of DAPK1 is an independent prognostic factor predicting survival in diffuse large B-cell lymphoma.
    Kristensen LS; Asmar F; Dimopoulos K; Nygaard MK; Aslan D; Hansen JW; Ralfkiaer E; Grønbæk K
    Oncotarget; 2014 Oct; 5(20):9798-810. PubMed ID: 25229255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of epigenetic inactivation of p16, p15, MGMT and DAPK genes in follicular lymphoma.
    Krajnović M; Radojković M; Davidović R; Dimitrijević B; Krtolica K
    Med Oncol; 2013 Mar; 30(1):441. PubMed ID: 23275143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Promoter methylation and expression of death-associated protein kinase gene in acute leukemia].
    Zhao WH; Meng FY; Lai YR; Peng ZG; Ma J
    Nan Fang Yi Ke Da Xue Xue Bao; 2017 Mar; 37(3):407-410. PubMed ID: 28377362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TP53 hotspot mutations are predictive of survival in primary central nervous system lymphoma patients treated with combination chemotherapy.
    Munch-Petersen HD; Asmar F; Dimopoulos K; Areškevičiūtė A; Brown P; Girkov MS; Pedersen A; Sjö LD; Heegaard S; Broholm H; Kristensen LS; Ralfkiaer E; Grønbæk K
    Acta Neuropathol Commun; 2016 Apr; 4():40. PubMed ID: 27101868
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic significance of DAPK and RASSF1A promoter hypermethylation in non-small cell lung cancer (NSCLC).
    Niklinska W; Naumnik W; Sulewska A; Kozłowski M; Pankiewicz W; Milewski R
    Folia Histochem Cytobiol; 2009; 47(2):275-80. PubMed ID: 19926549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Promoter hypermethylation of RARβ2, DAPK, hMLH1, p14, and p15 is associated with progression of breast cancer: A PRISMA-compliant meta-analysis.
    Qi M; Xiong X
    Medicine (Baltimore); 2018 Dec; 97(51):e13666. PubMed ID: 30572486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Expression of death-associated protein kinase gene and methylation status of promoter region in acute leukemia].
    Niu YM; Wang PP; Wang Y; Wang YZ; Cai DL; Li Y
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Feb; 22(1):30-4. PubMed ID: 24598646
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.